- Goldman Sachs Upgrades Cepheid and Myriad, Restarts Thermo Fisher Coverage
September 23, 2011 / GenomeWeb Daily News
- Goldman Sachs Downgrades Cepheid to 'Neutral'
July 6, 2011 / GenomeWeb Daily News
- Leerink Swann Upgrades Illumina; Revises Estimates for Life Tech, Thermo Fisher, Others
July 23, 2012 / GenomeWeb Daily News
- Goldman Sachs Revises Estimates for Life Science Tools Firms
April 13, 2012 / GenomeWeb Daily News
- Credit Suisse Initiates Coverage of Illumina, Life Tech, Thermo Fisher, Cepheid, Qiagen, and Waters
December 15, 2011 / GenomeWeb Daily News